BRIEF-SuperX AI Technology To Sell 3.3 Million Units At $12.08 Each In Private Placement

BRIEF-SuperX AI Technology To Sell 3.3 Million Units At $12.08 Each In Private Placement - SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-SuperX AI Technology To Sell 3.3 Million Units At $12.08 Each In Private Placement - SEC Filing

Oct 24, 2025 2:24 PM

Oct 24 (Reuters) - SuperX AI Technology Ltd ( SUPX ):

* SUPERX AI TECHNOLOGY LTD ( SUPX ): AGREED TO ISSUE, SELL IN

PRIVATE

PLACEMENT AGGREGATE OF 3.3 MILLION UNITS AT US$12.08/PURCHASER

UNIT - SEC FILING

* SUPERX AI TECHNOLOGY ( SUPX ): PROCEEDS TO CO EXPECTED TO BE ABOUT

$39.9

MILLION, WITH POTENTIAL TO INCREASE BY US$13.3 MILLION IF

WARRANTS EXERCISED

Source text:

Further company coverage:

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： Tesla's sales in Sweden fall 53.7% year-on-year in May

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Tesla's sales in Sweden fall 53.7% year-on-year in May

Jun 2, 2025

STOCKHOLM (Reuters) -Tesla's new car sales in Sweden fell 53.7% in May from a year earlier to 503 vehicles, registration data from Mobility Sweden showed on Monday. ...

Sanofi to buy US biopharma group Blueprint for over $9 billion

Jun 2, 2025

* Sanofi to pay $129 per share in cash * Deal to enhance Sanofi's rare and immunology portfolios * Would be one of biggest in Europe so far this year (Adds details and background throughout, shares) PARIS, June 2 (Reuters) - France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation ( BPMC ) for over $9 billion to boost...

Novartis' Pluvicto shown to slow prostate cancer in earlier setting

Jun 2, 2025

FRANKFURT (Reuters) -Novartis said on Monday that its targeted radiotherapy Pluvicto was shown to slow progression of a certain type of prostate cancer, raising the prospect of treatment in an earlier disease stage for a drug technology that the drugmaker has pioneered. The Swiss drugmaker reported a late-stage trial showed a clinically meaningful benefit in progression-free survival with a positive...